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Abstract 
Background: The rapid increase of extended-spectrum beta-lactamase (ESBL) producing bacteria are a potential 
health hazard. Development of antimicrobial resistance in animal pathogens has serious implications for human 
health, especially when such strains could be transmitted to human. In this study, the antimicrobial resistance due to 
ESBL producing Pseudomonas aeruginosa in the camel meat was investigated.
Methods: In this study meat samples from 200 healthy camels at two major abattoirs in Egypt (Cairo and Giza) were 
collected. Following culture on cetrimide agar, suspected P. aeruginosa colonies were confirmed with a Vitek 2 system 
(bioMe´rieux). P. aeruginosa isolates were phenotypically identified as ESBL by double disk synergy test. Additionally 
antimicrobial susceptibility testing of ESBL producing P. aeruginosa isolates were done against 11 antimicrobial drugs 
and carried out by disk diffusion method. The ESBL genotypes were determined by polymerase chain reaction accord-
ing to the presence of the blaPER-1, blaCTX-M, blaSHV, and blaTEM.
Results: Pseudomonas aeruginosa was isolated from 45 camel meat sample (22.5%). The total percentage of ESBL 
producing P. aeruginosa was 45% (21/45) from camel meat isolates. Antibiogram results revealed the highest resist-
ance was for c, ceftriaxone and rifampicin followed by cefepime and aztreonam. The prevalence rates of β-lactamase 
genes were recorded (blaPER-1 28.5%, blaCTX-M 38%, blaSHV 33.3% and blaTEM 23.8%).
Conclusions: This study illustrates the presence of high rates of ESBL-P. aeruginosa in camels that represents an 
increasing alarming for the risk of transmission to human and opens the door for current and future antibiotics 
therapy failure. Livestock associated ESBL-P. aeruginosa is a growing disaster, therefore, attention has to be fully given 
to livestock associated ESBL-bacteria which try to find its way to human beings.
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Background
The increasing resistance of potentially pathogenic bacte-
ria to multiple conventional antibiotics is an urgent prob-
lem in global public health [1]. Pseudomonas aeruginosa 
is one of the major causes of diseases such as otitis, mas-
titis, endometritis, hemorrhagic pneumonia and urinary 
tract infections in both livestock and companion animals 
[2–4]. The multiple-drug-resistant (MDR) Pseudomonas 
can be transmitted from different sources to humans and 
also to the environment through horizontal gene, the 
emergence and occurrence of MDR P. aeruginosa strains 
are growing in the world, leading to limited therapeutic 
options [5, 6].
The prevalence of MDR enterobacteriaceae in slaugh-
terhouses, including swine and poultry environments, 
has been reported in several studies building a growing 
alarm about their effect on animal and human health 
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[7, 8]. Recently encountered the emergence of livestock 
associated ESBL-producing P. aeruginosa in cow, poultry 
and pigs [9, 10].
In Middle East region, camels are important in the live-
stock economy by their adaptability to adverse environ-
mental conditions and naturally resistant to most of the 
diseases commonly affecting livestock [11]. Camels pro-
vide milk, meat, wool, hides, and skin, and their dung is 
used for fires [12]. They are acting one of major and good 
sources of protein and income for developing countries.
Transmission of ESBL-producing gram-negative bac-
teria between food-producing animals and humans via 
direct contact or meat is supposed [13]. Accordingly, live-
stock associated ESBL-producing gram-negative bacteria 
become new alarm for emerging infectious pathogens to 
human and animals.
This study aimed to investigate the role of camels as a 
risky reservoir and disseminating carrier of ESBL produc-
ing P. aeruginosa especially as this micro-organism has 
the ability of producing multidrug resistant enzymes that 
could be easily disseminated in the community via livestock 
products, particularly through direct contact and/or con-
sumption of meat as well as other infected animal products.
Methods
Camel meat samples
This study was carried out on 200 apparently healthy 
camels. These camels were selected from two major abat-
toirs (Cairo and Giza) from April to September 2015. 
Meat samples from slaughtered camels in the abattoirs 
were collected in sterile containers and sent on ice to the 
microbiology department laboratory.
Meat samples preparation
Twenty-five grams of the collected meat samples were 
weighed and transferred to sterile flasks contain-
ing 100  ml of phosphate buffer saline (PBS). Samples 
were homogenized using a meat grinder under aseptic 
conditions.
Isolation and identification of P. aeruginosa
Two hundred meat samples were cultured into cetrimide 
agar, the plates were incubated aerobically at 37  °C for 
24 h. The putative colonies were examined for their colo-
nial morphology and microscopically according to Quinn 
et  al. [14], the purified isolates of P. aeruginosa were 
finally confirmed with a Vitek 2 system (bioMe´rieux) 
which is rapid and reliable identification method.
Phenotypic detection of ESBL by double‑disk synergy test 
method (DDST)
ESBL production in P. aeruginosa was identified by the 
double disk synergy test (DDST) as described by Jarlier 
[15]. Mueller–Hinton agar was inoculated with standard-
ized inoculum (corresponding to 0.5 McFarland tube) 
using a sterile cotton swab. An Augmentin (20 μg amoxi-
cillin and 10 μg of clavulanic acid-AMC) disk was inserted 
in the center of the plate and test disks of 3rd genera-
tion cephalosporins (ceftazidime-CAZ 30  μg, ceftriax-
one-CRO 30 μg, cefotaxime-CTX 30 μg) and aztreonam 
(ATM 30 μg) disks were placed at 20 mm distance (center 
to center) from the amoxicillin clavulanic acid disk. The 
plate was incubated overnight at 37  °C. Enhancement of 
the zone of inhibition of any one of the four drug disks 
toward amoxicillin–clavulanic acid suggested the pres-
ence of extended-spectrum beta-lactamases.
Escherichia coli 25922 was used as a negative control 
for the ESBL and P. aeruginosa ATCC 27853 was used as 
a control strain for a positive ESBL.
Antimicrobial susceptibility testing
Antibiotic susceptibility tests were performed for ESBL 
producing P. aeruginosa isolates by using the standard 
disc diffusion method (Kirby–Bauer) on Mueller–Hin-
ton agar plates. The standard procedures of the CLSI, 
2015 and British Society for Antimicrobial Chemother-
apy (BSAC) disc diffusion method were strictly followed 
[16, 17], accordingly the antimicrobial susceptibility of P. 
aeruginosa strains were tested against 11 antimicrobial 
drugs: aztreonam (30  μg), ceftazidime (30  μg), ceftri-
axone (30  μg), cefepime (30  μg), amikacin (30  μg), gen-
tamicin (10  μg), ciprofloxacin (5  μg), rifamycin (30  µg), 
imipenem (10  μg), meropenem (1  μg) and sulphameth-
oxazole/trimethoprim (25 µg). E. coli ATCC 25922 and P. 
aeruginosa ATCC 27853 were used as quality controls.
DNA extraction
The whole genomic DNA from ESBL resistant P. aer-
uginosa strains totaling 21 was extracted using QIAamp 
Mini Kit (QIAGEN, Hombrechtikon, Switzerland) 
according to the manufacturer’s instructions.
Molecular detection of ESBL‑encoding genes
PCRs for detection of the blaPER-1, blaCTX-M, blaSHV and 
blaTEM genes. Specific primers for amplifying the selected 
genes by PCR are shown in Table 1.
The reaction mixture consisted of 25 µl Platinum™ Hot 
Start PCR Master Mix (Invitrogen™), 1 µl DNA extract, 
0.5  µl of each primer in the concentration of (20  pmol) 
and nuclease free water up to 50  µl. The cycling condi-
tions included denaturation for 10  min at 95  °C, ampli-
fication for 30 cycles of 30  s at 95  °C, 1  min at 55  °C, 
and 1  min at 72  °C, and extension for 10  min at 72  °C. 
The PCR products were resolved by electrophoresis on 
1.5% (wt/vol) agarose gels (QIAGEN, Hombrechtikon, 
Switzerland).
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Results
Isolation and identification of P. aeruginosa
Forty-five isolates (22.5%) from meat samples of 200 
camels were produced characteristic growth features of 
Pseudomonas species on the cetrimide agar medium. The 
isolates were obtained as one specific colony per camel 
meat sample. The isolates were confirmed as by Vitek 2 
system (bioMe´rieux).
Phenotypic detection of ESBL by double‑disk synergy test 
method (DDST)
Phenotypic detection of ESBL by DDST revealed that 21 
P. aeruginosa isolates. Accordingly, a total percentage of 
ESBL was detected in overall, 45% (21/45) from camel 
meat isolates.
Antimicrobial susceptibility testing
The results of the antimicrobial susceptibility testing for 
the 21 ESBL P. aeruginosa shows a high-level resistance 
(100%) to ceftazidime, ceftriaxone and rifampicin fol-
lowed by cefepime (95.2%) and aztreonam (76.1%). The 
susceptibilities of the isolates to meropenem, amikacin, 
imipenem, gentamicin and ciprofloxacin were 85.8, 81.0, 
76.2, 71. 4 and 66.7 respectively (Table 2).
Molecular detection of ESBL‑encoding genes
PCR screening of genes encoding ESBL revealed the 
amplification of blaPER-1, blaCTX-M, blaSHV and blaTEM 
genes in all tested isolates except three isolates coded p-4, 
-11, and -18 did not harbor any of ESBL genes (Table 3).
Furthermore, eight out of 21 ESBL-positive isolates had 
the blaCTX-M (38%), seven had blaSHV gene (33.3), and six 
carried blaTEM and blaPER genes (28.5).
Discussion
Extended-spectrum beta lactamase-producing bacte-
ria are one of the fastest emerging resistance problems 
worldwide. ESBL-producing bacteria were observed 
in human medical practice, the observation of these 
bacteria in companion animals and the increase in live-
stock has initiated monitoring studies concentrating on 
livestock [13, 21].
Livestock may be an important vehicle for the com-
munity-wide dissemination of antimicrobial-resistant 
Enterobacteriaceae, also P. aeruginosa especially ESBL-
producing type isolates have been found in increasing 
numbers in food-producing animals [9, 10, 22].
Accordingly to the hypothesis that animals might 
become infection sources or even natural persistent 
sources acting as risky reservoirs of infection leading to 
the spread of these bacteria specifically multidrug resist-
ant types in community [23]. There are essential needs 
for monitoring or surveillance studies incorporating vet-
erinary medicine to identify transmissible pathogens to 
human and its risk factors.
The dromedary camel is a good source of meat, espe-
cially in areas where the climate adversely affects the 
performance of other meat animals. This is because of 
the unique physiological characteristics of camels [24]. 
The interest for camel meat seems by all accounts to be 
expanded because of wellbeing reasons, as it contains 
Table 1 Primers used for detection of resistance genes
One uni plex PCR for detection of blaTEM gene and two multiplex PCR were conducted for the (blaPER-1 and blaCTX-M) and another one for (blaSHV) gene
Target gene Primer sequence (5′–3′) Product size (bp) References
blaPER-1 F: ATGAATGTCATTATAAAAGC 926 [18]
R: TTAATTTGGGCTTAGGG
blaCTX-M F: GCGATGGGCAGTACCAGTAA 392
R: TTACCCAGCGTCAGATTCCG
blaSHV F: TCAGCGAAAAACACCTTG 472 [19]
R: TCCCGCAGATAAATCACCA
blaTEM F: ATGAGTATTCAACATTTCCG 861 [20]
R: TTACCAATGCTTAATCAGTGAG
Table 2 Antibiotic resistance pattern of  21 Pseudomonas 
aeruginosa isolates
Antibiotic No (%) resistant No (%) sensitive
Amikacin (30 μg) 4 (19.0) 17 (81.0)
Imipenem (10 μg) 5 (23.8) 16 (76.2)
Gentamicin (10 μg) 6 (28.5) 15 (71.4)
Ciprofloxacin (5 μg) 7 (33.3) 14 (66.7)
Sulphamethoxazole/trimethoprim 
(25 µg)
8 (38.0) 13 (61.9)
Rifampicin (30 μg) 21 (100) –
Ceftriaxone (30 μg) 21 (100) –
Cefepime (30 μg) 20 (95.2) 1 (4.7)
Aztreonam (30 μg) 15 (76.1) 6 (28.5)
Meropenem (1.0 μg) 3 (14.2) 18 (85.8)
Ceftazidime (30 μg) 21 (100) –
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less fat and in addition less cholesterol and generally high 
polyunsaturated unsaturated fats than other animal’s 
meat [25].
To the best of our knowledge, this is the first time that 
an attempt has been made to determine ESBL P. aerugi-
nosa resistance in camel meat. In this study, the preva-
lence of P. aeruginosa in camel was determined about 
22.5% (45/200). This percent is so higher to the encoun-
tered investigations on fish and cow in Switzerland and 
Nigeria [9, 26]. Even though P. aeruginosa is ubiquitous, 
the prevalence of its isolation among camel isolates in 
this study was lower compared to the presence rate of E. 
coli that isolated from camel in Saudi Arabia with 26.0% 
[27].
Class A (ESBLs) are typically identified in P. aeruginosa 
isolates and showing resistance to the extended-spec-
trum cephalosporin (ESCs) [28], this resistance is often 
due to the production of β-lactamases. Clinically, ESBLs 
are generally encoded by plasmid-mediated bla genes; 
three major clinically relevant β-lactamase genes are 
blaSHV, blaTEM and blaCTX-M 2, 4 [29].
The total percentage of ESBL producing P. aeruginosa 
was 45% (21/45) from camel meat isolates by DDST, 
accordingly, the most frequently β-lactamase-genes 
detected in this isolates were blaCTX-M (38%), followed by 
blaSHV (33.3%) and blaTEM, balPER-1 (28.5%).
CTX-M enzymes have now become the most wide-
spread type of ESBL worldwide and represent the wide 
dissemination of particular plasmids or bacterial clones 
[30]. On the other hand, blaPER-1 were found to be the 
most prevalent type of β-lactamase-encoding genes in 
Acinetobacter baumannii in Egypt [31] and this suggests 
the horizontal transfer of this gene.
In the present study antibiogram of ESBL produc-
ing P. aeruginosa showed high-level resistance (100%) 
to ceftazidime, ceftriaxone and rifampicin followed by 
cefepime (95.2%) and aztreonam (76.1%).The susceptibili-
ties of the isolates to meropenem, amikacin, imipenem, 
gentamicin, ciprofloxacin and amikacin were 85.8, 81.0, 
76.2, 71.5 and 67% respectively (Table 2).
Pseudomonas aeruginosa and other gram negative bac-
teria with ESBLs contain other β-lactamases that makes 
difficult the phenotypic detection of ESBL [32], this issue 
need further investigation.
Many investigators focus on MDR P. aeruginosa from 
human. P. aeruginosa are multi-drug resistant to amika-
cin (17.25%), ciprofloxacin (27.59%), ceftriaxone varied 
from 51.00 to 73.00% and all the strains were susceptible 
Table 3 ESBL resistance genes percent and antibiotic pattern of multiple drug resistant strains
MDR Multiple drug resistant
Isolates Resistance gene pattern Antimicrobial resistance Antibiotic pattern
blaPER-1 blaCTX-M blaSHV blaTEM
P-1 + + CAZ, CRO, RD, FEP, ATM, AK, CN, CIP MDR
P-2 + + + CAZ, CRO, RD, FEP, ATM, MEM MDR
P-3 + + CAZ, CRO, RD, FEP, ATM, CIP MDR
P-4 CAZ, CRO, RD, FEP, ATM, CN MDR
P-5 + CAZ, CRO, RD, FEP, IPM MDR
P-6 + CAZ, CRO, RD, FEP, ATM, SXT MDR
P-7 + + CAZ, CRO, RD, FEP, ATM, IPM MDR
P-8 + + CAZ, CRO, RD, FEP, ATM,AK, CIP MDR
P-9 + + CAZ, CRO, RD, FEP, ATM, MEM, CIP, SXT MDR
P-10 + CAZ, CRO, RD, FEP, CN, CIP MDR
P-11 CAZ, CRO, RD, FEP, ATM, CIP MDR
P-12 + CAZ, CRO, RD, FEP, AK, CIP MDR
P-13 + + CAZ, CRO, RD, FEP, CN MDR
P-14 + CAZ, CRO, RD, FEP, IPM, SXT MDR
P-15 + CAZ, CRO, RD, FEP, AK, CN MDR
P-16 + CAZ, CRO, RD, FEP, ATM, SXT MDR
P-17 + + CAZ, CRO, RD, FEP, ATM, SXT MDR
P-18 CAZ, CRO, RD, FEP, IPM, CN MDR
P-19 + CAZ, CRO, RD, FEP, SXT MDR
P-20 + CAZ, CRO, RD, FEP, ATM, IPM, SXT MDR
P-21 + CAZ, CRO, RD, MEM, SXT MDR
% (6/21) 28.5 (8/21) 38 (7/21) 33.3 (6/21) 28.5
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to imipenem (20.69%) [33]. High resistance to amino-
glycosides had been reported in Malaysia [34]. Similarly 
higher rates of resistance to fluoroquinolones such as cip-
rofloxacin (40.5%) had been reported in a study done in 
India. Lesser rate of resistance to ceftriaxone (40%) had 
been reported in Andhra Pradesh, India [35].
The presence of high resistance profile by camel P. aer-
uginosa isolates my attributed antibiotics used in man-
agement of this animals or natural resistance of camel 
that suites it as a risk reservoir for such pathogens.
Conclusion
The present study demonstrates, for the first time in 
Egypt, the presence a high rate of ESBL-P. aeruginosa in 
camels, The abundance MDR P. aeruginosa from camel 
meat in this study suggests a potential risk of human 
susceptibility to such pathogen group which remodels 
the epidemiology of antibiotic resistance. Urgent con-
trol measures are necessary to be applied to restrict the 
continuous abuse of antibiotics, especially in livestock 
production.
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